IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

ZANICHELLI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.828
AS - Asia 4.992
EU - Europa 4.905
SA - Sud America 443
AF - Africa 116
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 21
Totale 16.330
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.626
CN - Cina 1.470
GB - Regno Unito 1.435
SG - Singapore 1.433
IT - Italia 1.016
HK - Hong Kong 527
BD - Bangladesh 412
RU - Federazione Russa 405
DE - Germania 376
SE - Svezia 336
VN - Vietnam 334
BR - Brasile 301
FR - Francia 286
NL - Olanda 220
IN - India 194
FI - Finlandia 182
IE - Irlanda 150
KR - Corea 150
TR - Turchia 134
CA - Canada 122
UA - Ucraina 109
JP - Giappone 100
ES - Italia 86
EU - Europa 55
ID - Indonesia 51
AR - Argentina 48
DK - Danimarca 48
PL - Polonia 45
CI - Costa d'Avorio 44
CO - Colombia 42
MX - Messico 40
BE - Belgio 33
AT - Austria 28
UZ - Uzbekistan 26
PT - Portogallo 24
IQ - Iraq 20
AU - Australia 19
CH - Svizzera 19
GR - Grecia 17
TH - Thailandia 17
CL - Cile 16
RO - Romania 16
ZA - Sudafrica 15
AE - Emirati Arabi Uniti 14
PH - Filippine 14
TW - Taiwan 14
CZ - Repubblica Ceca 13
SA - Arabia Saudita 12
EC - Ecuador 11
IR - Iran 11
KE - Kenya 11
LT - Lituania 10
MA - Marocco 10
NP - Nepal 9
PK - Pakistan 9
IL - Israele 8
PE - Perù 8
BG - Bulgaria 7
HU - Ungheria 7
TN - Tunisia 7
AL - Albania 6
EG - Egitto 6
JO - Giordania 6
MY - Malesia 6
NO - Norvegia 6
NZ - Nuova Zelanda 6
PY - Paraguay 6
CR - Costa Rica 5
DZ - Algeria 5
HR - Croazia 5
JM - Giamaica 5
TT - Trinidad e Tobago 5
ET - Etiopia 4
LV - Lettonia 4
RS - Serbia 4
UY - Uruguay 4
VE - Venezuela 4
DO - Repubblica Dominicana 3
GT - Guatemala 3
HN - Honduras 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NI - Nicaragua 3
SC - Seychelles 3
SI - Slovenia 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CW - ???statistics.table.value.countryCode.CW??? 2
LU - Lussemburgo 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SN - Senegal 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AM - Armenia 1
Totale 16.341
Salva come PNG Salva come JPEG
Città #
Southend 1.172
Singapore 765
Ashburn 571
Hong Kong 438
Chandler 423
San Jose 395
Milan 322
Dallas 281
Beijing 260
New York 235
Santa Clara 213
Fairfield 176
Council Bluffs 175
Wilmington 168
Seattle 163
Los Angeles 153
Princeton 145
Dublin 134
Boardman 116
Ann Arbor 110
Ho Chi Minh City 103
Lauterbourg 101
Helsinki 99
Houston 89
Hanoi 87
Woodbridge 87
Guangzhou 76
Buffalo 74
Dearborn 74
Nanjing 74
Bengaluru 73
Redwood City 73
Jacksonville 71
Mountain View 66
Redmond 64
Tokyo 64
Frankfurt am Main 63
Moscow 60
Chester 57
Seoul 57
Hefei 55
Des Moines 52
Shanghai 51
Cambridge 50
Somerville 47
Abidjan 44
Jinan 42
Toronto 41
Rome 38
Jakarta 37
Lappeenranta 35
Phoenix 35
Sakarya 33
Shenyang 32
Tianjin 32
London 31
Munich 31
Serra 31
Berlin 30
Cangzhou 30
Columbus 30
Nanchang 30
Wuhan 30
Bogotá 29
Zhengzhou 29
Andover 28
Brussels 28
Chicago 28
São Paulo 27
Philadelphia 26
Hangzhou 25
Barcelona 24
Warsaw 24
Istanbul 23
Mumbai 23
Changsha 22
Fremont 22
Orem 22
Atlanta 20
Turin 20
Nuremberg 19
Rio de Janeiro 19
The Dalles 19
Fuzhou 18
Pisa 18
Saint Petersburg 18
Duncan 17
Naples 17
Palermo 17
San Diego 17
Washington 17
Shenzhen 16
Boston 15
Buenos Aires 15
Roxbury 15
Amsterdam 14
Athens 14
Bologna 14
Da Nang 14
Haiphong 14
Totale 9.541
Salva come PNG Salva come JPEG
Nome #
Current and emerging biologics for the treatment of hereditary angioedema 769
Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency 409
High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibtor deficiency 370
Effect of Lanadelumab Compared with Placebo on Prevention of Hereditary Angioedema Attacks : a Randomized Clinical Trial 366
A transcriptomics study of hereditary angioedema attacks 362
Gene regulation in the pathogenesis of angioedema due to inherited c1 inhibitor deficiency (hereditary angioedema) 305
Oral plasma kallikrein inhibitor for prophylaxis in hereditary angioedema 294
Angioedema without urticaria : a large clinical survey 281
Structural and functional characterization of mutations in C1-ihn responsible for hereditary angioedema 268
Angioedema da ACE-inibitori: risultati dopo il passaggio ad una diversa terapia antiipertensiva 267
Hereditary angioedema: Assessing the hypothesis for underlying autonomic dysfunction 264
Successful resolution of bowel obstruction in a patient with hereditary angioedema 262
Hereditary and acquired angioedema : problems and progress : proceedings of the third C1 esterase inhibitor deficiency workshop and beyond 258
Effects of mutations within the coding region of C1-INH gene on disease manifestation and protein function in families with HAE 250
Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency 235
Mechanisms of C1-inhibitor deficiency 230
Efficacy of on-demand treatment in reducing morbidity in patients with hereditary angioedema due to C1 inhibitor deficiency 228
A SERPING1 variant that causes C1-inhibitor deficiency without hereditary angioedema 227
Use of C1 inhibitor concentrate for treatment of angioedema attacks in patients with C1 inhibitor deficiency : survey of 1102 infusions in 503 patients 222
C1 inhibitor : molecular and clinical aspects 221
Angioedema and angiotensin-converting enzyme inhibitor use : results after switching to a different antihypertensive therapy 217
Acquired deficiency of the inhibitor of the first complement component : presentation, diagnosis, course, and conventional management 217
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy 214
Established and new treatments for hereditary angioedema : an update 213
Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency 210
C1-inhibitor deficiency and angioedema : molecular mechanisms and clinical progress 206
Emotional processes and stress in children affected by hereditary angioedema with C1-inhibitor deficiency : a multicenter, prospective study 205
Long-term safety of icatibant treatment of patients with angioedema in real-world clinical practice 203
The use of plasma-derived C1 inhibitor in the treatment of hereditary angioedema 202
Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema 202
Patterns of C1-Inhibitor Plasma Levels and Kinin–Kallikrein System Activation in Relation to COVID-19 Severity 196
Plasmatic markers of acute attack in patients with angioedemadue to C1 inhibitor deficiency 191
C1 inhibitor function and anti-C1 inhibitor autoantibodies in patients with HIV type 1 infection 190
Costs and effects of on-demand treatment of hereditary angioedema in Italy : a prospective cohort study of 167 patients 189
Catabolism of C1 inhibitor influences the response to replacement therapy in hereditary angioedema 185
Current treatment options for hereditary angioedema due to C1 inhibitor deficiency 185
Hereditary angioedema due to C1 inhibitor deficiency in Belarus : epidemiology, access to diagnosis and seven novel mutations in SERPING1 gene 182
Acquired C1 esterase inhibitor deficiency in two patients presenting with a lupus-like syndrome and anticardiolipin antibodies 179
Two Cases Of Peculiar Hypereosinophilic Syndrome Treated With Mepolizumab 178
Angioedema without urticaria in 929 Italian patients : proposal for a diagnostic and therapeutic approach 177
C1 esterase inhibitor and the kinin-kallikrein system in COVID-19 176
A COSMIN systematic review of instruments for evaluating health-related quality of life in people with Hereditary Angioedema 173
Acquired angioedema 172
Secreted phospholipases A2 in hereditary angioedema with C1-inhibitor deficiency 171
The Global Registry for Hereditary Angioedema due to C1-Inhibitor Deficiency 163
The Acquired Deficiency of C1-Inhibitor: Lymphoproliferation and Angioedema 160
Multicentric Observational Study on Safety and Tolerability of COVID-19 Vaccines in Patients with Angioedema with C1 Inhibitor Deficiency: Data from Italian Network on Hereditary and Acquired Angioedema (ITACA) 156
Angioedema Phenotypes : Disease Expression and Classification 154
The safety of treatments for angioedema with hereditary C1 inhibitor deficiency 154
Comorbidities in Angioedema Due to C1-Inhibitor Deficiency: An Italian Survey 148
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema 145
Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor 145
Standard care impact on angioedema because of hereditary C1 inhibitor deficiency : a 21-month prospective study in a cohort of 103 patients 140
Angioedema during ACE inhibitor treatment: a long term follow-up 138
Real-Life Experience With Subcutaneous Plasma-Derived C1-Inhibitor for Long-Term Prophylaxis in Patients With Hereditary Angioedema: A Case Series 137
Angioedema due to C1 inhibitor deficiency in 2010 136
A long follow-up of patients presenting angioedema during ACE inhibitor treatment 130
Hereditary angioedema treatment beyond biologics: current state of preventive and on-demand approaches and new perspectives 129
Efficacy of Lanadelumab in angioedema due to acquired C1 inhibitor deficiency 123
Cleaved kininogen as a biomarker for bradykinin release in hereditary angioedema 123
Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies : from pathophysiology to the clinic 123
Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts. 122
Ecallantide for treatment of acute attacks of acquired C1 esterase inhibitor deficiency 120
Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency : clinical and molecular characterization 120
Hereditary Deficiency of C1 Inhibitor and Angioedema 119
Structural and functional characterization of mutations in C1-inh responsible for hereditary angioedema 117
Treatment of acquired angioedema with icatibant: a case report 116
Replacement therapy with C1 esterase inhibitors for hereditary angioedema 113
High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin mediated angioedema due to hereditary c1-inhibitor deficiency 110
Experience on Series Production of the HL-LHC Superferric High Order Corrector Magnets 106
Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema 101
Icatibant treatment for acquired C1-inhibitor deficiency : a real-worldobservational study 99
Lanadelumab’s impact on hereditary angioedema control and quality of life across disease activity subgroups 98
Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study 96
Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: Findings from the Icatibant Outcome Survey 93
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial 89
Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus 83
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. 83
Diagnosing angioedema 83
The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update 79
The Chronic Angioedema Registry (CARE): Rationale, Methods and Implementation 78
International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency 76
Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients 75
Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence 72
Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment 71
DAB2IP associates with hereditary angioedema: Insights into the role of VEGF signaling in HAE pathophysiology 70
Rare connective tissue diseases in patients with C1-inhibitor deficiency hereditary angioedema: first evidence on prevalence and distribution from a large Italian cohort study 69
Hereditary angioedema diagnosis: Reflecting on the past, envisioning the future 68
Measurement of cleaved high-molecular-weight kininogen in patients with hereditary angioedema due to C1-inhibitor deficiency: preanalytical and analytical optimization 67
Long-Term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label Extension 64
Acquired C1-inhibitor deficiency and lymphoproliferative disorders: A tight relationship 63
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks 63
Diagnostic testing for chronic spontaneous urticaria with or without angioedema: The do's, don't and maybe's 62
Lanadelumab for prevention of attacks of non-histaminergic normal C1 inhibitor angioedema: results from the randomized, double-blind CASPIAN Study and CASPIAN open-label extension 58
Psychological processes in the experience of hereditary angioedema in adult patients: an observational study 54
Self-Care Experiences and Behaviours in People With Parkinson’s Disease: A Meta-Synthesis 54
Evaluation of patient-reported outcome measures for on-demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat 51
Assessment of potential drug-drug interactions in patients with hereditary angioedema from the ITACA cohort: simulations from a real-life dataset considering danazol versus berotralstat 51
The experience of living with a chronic disease in pediatrics from the mothers’ narratives: The Clinical Interview on Parental Sense of Grip on the Disease 48
Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor 47
Totale 16.333
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.686
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 0 0 0 0 0 0 51
2021/2022885 79 32 44 47 45 56 81 59 111 80 55 196
2022/20231.243 148 153 125 157 92 223 26 77 143 18 66 15
2023/2024781 22 55 42 44 198 141 25 46 18 46 70 74
2024/20252.055 72 143 30 178 154 95 60 215 183 271 182 472
2025/20267.052 448 327 545 418 815 499 915 441 788 497 815 544
Totale 17.190